{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:45:47Z","timestamp":1784231147114,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"General Scientific Research Project of Lianyungang Municipal Health and Family Planning Commission","award":["F-201834"],"award-info":[{"award-number":["F-201834"]}]},{"name":"Maternal and Child Health Research Project of Jiangsu Province","award":["1-201433"],"award-info":[{"award-number":["1-201433"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>This study investigated the feasibility of predicting the expression levels of Ki-67 in breast cancer using ultrasonographic findings and clinical features.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fifty-eight breast cancer patients, with 82 lesions confirmed by surgical pathology, were selected retrospectively for this study. Conventional ultrasound examination and elastography examination were performed before surgery. Clinical features (age, estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor-2 expression levels), ultrasonographic findings, and elastography scores, including the maximum size, location, number, margin, borderline, blood flow, and elastography score of the mass, were collected. The expression of Ki-67 was recorded using immunohistochemical staining, and the patients were divided into a high (\u2265\u200920%) expression group and a low (&lt;\u200920%) expression group. SPSS 23.0 software was used for statistical analysis. An independent sample t-test was used for measurement data, and a \u03c7<jats:sup>2<\/jats:sup> test was used for enumeration data. Logistic regression analysis was performed for meaningful indicators, and the receiver operating characteristic curve was used to calculate the best diagnostic cut-off point.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Monofactorial analysis showed that there was a statistically significant difference (p\u2009&lt;\u20090.05) between the high expression of Ki-67 and the maximum diameter of the mass, the margin of the mass, the color Doppler flow imaging of the blood flow, and the resistance index of the blood flow. There were no significant differences in age, mass location, number, morphology, borderline, microcalcification, and elastography score (p\u2009&gt;\u20090.05). Multiple factor regression analysis showed that a large mass and a mass with a rich blood flow had an independent predictive value for Ki-67. When the diameter was\u2009&gt;\u200921.5\u00a0mm, the diagnostic sensitivity and specificity were 91.9% and 71.3%, respectively. The expression level of Ki-67 was negatively correlated with that of ER.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The tumor size and blood flow of breast cancer is correlated with the expression level of Ki-67 and, thus, it could be used to predict the expression level of Ki-67 in ultrasound diagnosis. The margin condition and the expression level of ER of an ultrasonic mass could also indirectly reflect the Ki-67 expression level of the mass.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12880-021-00684-3","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T13:33:03Z","timestamp":1634391183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters"],"prefix":"10.1186","volume":"21","author":[{"given":"Chen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,16]]},"reference":[{"issue":"4","key":"684_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","volume":"26","author":"LA Torre","year":"2017","unstructured":"Torre LA, Islami F, Siegel RL, et al. Global cancer in women: burden and trends. Cancer Epidemiol Biomark Prev. 2017;26(4):444\u201357.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"684_CR2","doi-asserted-by":"publisher","first-page":"A137","DOI":"10.1016\/j.jval.2016.03.1644","volume":"19","author":"D Mitra","year":"2016","unstructured":"Mitra D, Kurosky S, Zanotti G, et al. Real-world treatment patterns and clinical outcomes in Er+\/Her2-metastatic breast cancer: results from a multicountry retrospective medical record review. Value Health. 2016;19(3):A137.","journal-title":"Value Health"},{"key":"684_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-9245-0","volume-title":"Biomarkers of cancer\/\/applications of biotechnology in oncology","author":"KK Jain","year":"2014","unstructured":"Jain KK. Biomarkers of cancer\/\/applications of biotechnology in oncology. New York: Springer; 2014."},{"key":"684_CR4","first-page":"1603","volume":"7","author":"L Xue","year":"2018","unstructured":"Xue L, Zhao X, Cai J, et al. The expression of ER, PR, C-erbb-2 and Ki-67 in breast cancer patients and their relationship with ultrasonic signs. Chin J Gerontol. 2018;7:1603\u20135.","journal-title":"Chin J Gerontol"},{"key":"684_CR5","doi-asserted-by":"crossref","unstructured":"Seo SH, Kim KH, Oh SH, et al. Ki-67 labeling index as a prognostic marker in advanced stomach cancer. Ann Surg Treat Res. 2019;96(1).","DOI":"10.4174\/astr.2019.96.1.27"},{"issue":"6","key":"684_CR6","first-page":"739","volume":"4","author":"J Hou","year":"2010","unstructured":"Hou J, Zeng J, Wu H, et al. Expression and correlation of epidermal growth factor receptor 2 and estrogen receptor and progesterone receptor in breast cancer. Chin J Clin Phys (Electron Ed). 2010;4(6):739\u201343.","journal-title":"Chin J Clin Phys (Electron Ed)"},{"key":"684_CR7","doi-asserted-by":"crossref","unstructured":"Amornsiripanitch N, Nguyen VT , Rahbar H, et al. Diffusion-weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+\/HER2- breast cancers. J Mag Resonan Imaging. 2017.","DOI":"10.1002\/jmri.25909"},{"issue":"04","key":"684_CR8","first-page":"24","volume":"35","author":"J Gao","year":"2019","unstructured":"Gao J, Wang Y, Yang L, et al. Contrast-enhanced ultrasonography (CEUS) and its correlation with biological prognostic factors in breast cancer. Chin J Ultrasound Med. 2019;35(04):24\u20137.","journal-title":"Chin J Ultrasound Med"},{"issue":"11","key":"684_CR9","first-page":"1237","volume":"34","author":"L Zhu","year":"2019","unstructured":"Zhu L, Lou J, Wang S, et al. Microcalcification in ductal carcinoma in situ of the breast: a comparative study. Radiol Practice. 2019;34(11):1237\u201341 ((in Chinese)).","journal-title":"Radiol Practice"},{"issue":"3","key":"684_CR10","first-page":"31","volume":"10","author":"C Cheng","year":"2018","unstructured":"Cheng C, Zhou S, Zhou J, et al. Clinical value of improved ultrasound elastography score and ultrasound elastic strain ratio in bi-RADS type 4 breast tumor. Chin J Med Front (Electron Edn). 2018;10(3):31\u20135.","journal-title":"Chin J Med Front (Electron Edn)"},{"issue":"11","key":"684_CR11","first-page":"1008","volume":"26","author":"X Ye","year":"2017","unstructured":"Ye X, He M. Real-time shear wave elastography in breast diseases: a review. Ultrasonics Ultrasound. 2017;26(11):1008\u201311 ((in Chinese)).","journal-title":"Ultrasonics Ultrasound"},{"issue":"3","key":"684_CR12","first-page":"337","volume":"34","author":"L Ye","year":"2019","unstructured":"Ye L, Wang L, Wang X, et al. Real-time shear wave elastography for the evaluation of anisotropy and benign and malignant breast mass. Radiol Practice. 2019;34(3):337\u201341.","journal-title":"Radiol Practice"},{"issue":"006","key":"684_CR13","first-page":"422","volume":"009","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liu WH, Wang R, et al. Correlation between apparent diffusion coefficient values of different B values in 3.0T magnetic resonance and prognostic factors and molecular typing of breast cancer. Mag Resonance Imaging. 2018;009(006):422\u20136.","journal-title":"Mag Resonance Imaging"},{"key":"684_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jsbmb.2013.04.003","volume":"137","author":"S Cunha","year":"2013","unstructured":"Cunha S, Gano L, Morals GR, et al. Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy. J Steroid Biochem Mol Biol. 2013;137:223\u201341.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"684_CR15","first-page":"23","volume":"5","author":"FF Qiu","year":"2019","unstructured":"Qiu FF. The diagnostic significance of ultrasound signs for different expression levels of HER2 and ER, PR, Ki-67 in breast cancer. J Baotou Med Coll. 2019;5:23\u20135.","journal-title":"J Baotou Med Coll"},{"key":"684_CR16","first-page":"488","volume":"2015","author":"M Versaci","year":"2015","unstructured":"Versaci M, Calcagno S, Morabito FC. Fuzzy geometrical approach based on unit hyper-cubes for image contrast enhancement. IEEE Int Conf Signal Image Process Appl (ICSIPA). 2015;2015:488\u201393.","journal-title":"IEEE Int Conf Signal Image Process Appl (ICSIPA)"},{"key":"684_CR17","first-page":"494","volume":"9257","author":"M Versaci","year":"2015","unstructured":"Versaci M, Calcagno S, Morabito FC. Image contrast enhancement by distances among points in fuzzy hyper-cubes. CAIP. 2015;9257:494\u2013505.","journal-title":"CAIP"},{"issue":"002","key":"684_CR18","first-page":"75","volume":"000","author":"Q Zheng","year":"2015","unstructured":"Zheng Q, Li S, Chen C, et al. Correlation between bi-RADS and ki-67 expression in breast cancer. J Mol Imaging. 2015;000(002):75\u20139.","journal-title":"J Mol Imaging"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-021-00684-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-021-00684-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-021-00684-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T20:21:28Z","timestamp":1634415688000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-021-00684-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1186\/s12880-021-00684-3","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,16]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I confirm that I have read the Editorial Policy pages. This study was conducted with approval from the Ethics Committee of First Affiliated Hospital of Soochow University. This study was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants signed a document of informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}